Join Now

Author Archives: Denise Bell

Senate aims to vote Wednesday on $2T coronavirus bill

By Denise Bell | Published March 25, 2020

Washington Post – The Senate is aiming to vote Wednesday on a $2 trillion stimulus package that is designed to flood the U.S. economy with money in an effort to stabilize households and businesses that have been floored by the coronavirus outbreak, according to an article published in the Washington Post. But Senate leaders were still working […]

Posted in COVID-19 Legislation, COVID-19 Updates, Economic Developments, Feature, Federal News | Leave a comment

Corporate Policy and Infectious Disease Response Plan

By Denise Bell | Published March 25, 2020

Develop an overriding policy for how the company will respond to a COVID-19 outbreak and impacts. Helpful resources: Click here to download a copy of the World Health Organization’s guide to developing a “Strategic Preparedness and Response Plan for the New Coronavirus” CDC Business and Employer Guidance Implement a plan of action for counseling employees who […]

Posted in COVID-19 Updates, Workplace Safety | Leave a comment

Coronavirus (COVID-19) Update: FDA takes action to increase U.S. supplies through instructions for PPE and device manufacturers

By Denise Bell | Published March 24, 2020

“March 24, 2020 – Today, the U.S. Food and Drug Administration took action to increase U.S. supplies to support the U.S. response to COVID-19 by providing instructions to manufacturersExternal Link Disclaimer importing personal protective equipment and other devices. One of FDA’s priorities in combating the COVID-19 pandemic is facilitating access to critical personal protective equipment (PPE) and […]

Posted in COVID-19 Updates, HHS/FDA & Other Regulatory | Leave a comment

Coronavirus (COVID-19) Update: FDA Continues to Facilitate Access to Crucial Medical Products, Including Ventilators

By Denise Bell | Published March 22, 2020

“‘Today, the U.S. Food and Drug Administration took significant action to help increase the availability of ventilators and accessories, as well as other respiratory devices, during the COVID-19 pandemic to support patients with respiratory failure or difficulty breathing. ‘The FDA’s new actions will mean America can make more ventilators during this crisis,’ said Health and Human Services […]

Posted in COVID-19 Updates, HHS/FDA & Other Regulatory | Leave a comment

Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide

By Denise Bell | Published March 20, 2020

Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals […]

Posted in Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

SEC adopts McAdams and Hollingsworth proposal to cut red tape on promising start-ups

By Denise Bell | Published March 18, 2020

Courtesy of mcadams.house.gov Washington, D.C.—Legislation by Congressman Ben McAdams and Congressman Trey Hollingsworth (R-IN) giving commonsense regulatory relief for America’s growing companies was essentially adopted by the Securities and Exchange Commission (SEC) in a rule-making action. McAdams introduced the Fostering Innovation Act in 2019 as a narrow fix that allows small emerging growth companies to keep capital […]

Posted in Federal News, Life Sciences Industry News | Leave a comment

The Department of Health and Human Services on PREP

By Denise Bell | Published March 16, 2020

The Department of Health and Human Services issued a declaration on March 16 under the Public Readiness and Emergency Preparedness (“PREP”) Act to provide immunity to liability for activities related to medical countermeasures against COVID-19. The declaration is effective retroactively to February 4, 2020. The notice will be published in the Federal Register March 17. […]

Posted in HHS/FDA & Other Regulatory, Life Sciences Industry News | Leave a comment

H.R. 6201, the Families First Coronavirus Response Act Passed by the House 363-40 (3/14/2020)

By Denise Bell | Published March 14, 2020

Article courtesy of the National Association of Manufacturers Emergency Family and Medical Leave Expansion and Paid Sick Leave: • Creates a new “Public Health Emergency Leave” program under the Family and Medical Leave Act. Private employers, including manufacturers, under 500 employees are required to cover workers for a wide range of circumstances related to COVID-19 […]

Posted in COVID-19 Updates, Federal News | Leave a comment

Travel Considerations

By Denise Bell | Published March 12, 2020

Limit travel to only essential travel and have a clear definition of what constitutes “essential travel.” Monitor and share travel advisories and warning with employees. Click here for international travel news. Click here for CDC’s live Travel Health Alert Notice. Suspend travel to affected areas Develop a policy to address employees who refuse to work with co-workers […]

Posted in COVID-19 Updates, Workplace Safety | Leave a comment

Maintaining a Safe Workplace

By Denise Bell | Published March 12, 2020

Identify possible work-related exposure and health risks to your employees. Train and educate employees about COVID-19. Here are some tools: Utah State Task Force Slide Deck Governor’s Recommendations Poster of Coronavirus symptoms for the work place Poster on “What you need to know and how to protect yourself from the Coronavirus” for the workplace Educational videos from the […]

Posted in COVID-19 Updates, Workplace Safety | Leave a comment

Co-Diagnostics, Inc. Invited to Speak on Coronavirus at Molecular Med Tri-Con in San Francisco

By Denise Bell | Published March 3, 2020

March 03, 2020 06:30 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests and that recently reported it had received a CE marking for its COVID-19 coronavirus assay, announced today that it has been requested to speak at […]

Posted in Life Sciences Events, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

BioUtah and the University of Utah’s TVC Announce Startups Chosen to Pitch at the 2020 Entrepreneur & Investor Life Science Summit 

By Denise Bell | Published February 24, 2020

Nine rising startup companies from Utah’s growing life sciences industry will present their innovations to investors during the 2020 Entrepreneur & Investor Life Science Summit on February 28, sponsored by Simpson Thacher Salt Lake City, Utah – February 24, 2020 – BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership with […]

Posted in Policy News | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members